High nuclear VDR expression was also associated with improved overall survival in NSCLC patients (adjusted HR = 0.36 95% CI 0.17, 0.79; p = 0.011) [111], while overexpression of CYP24A1 resulted in poorer survival (HR = 2.1 95% CI 1.14, 3.75; p = 0.001) [104]. This evidence concerns the gene CYP24A1 and non-small cell lung carcinoma.